Revolutionizing Dermatological Treatment: Almirall and AbSci Join Forces in Groundbreaking AI Drug Discovery Partnership
Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments VANCOUVER, Wash. and BARCELONA, Spain, Nov. 14, 2023 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, and Almirall S.A. (BME: ALM), a global biopharmaceutical company focused on medical dermatology, have announced a collaboration that will expand Absci’s…